Category

Covid-19
By Selina Wellbelove – 15 Nov 2021 Vaccinated patients with blood cancers experiencing breakthrough COVID-19 infections remain at high risk for severe or critical disease and death, new research shows. Furthermore, it was found that patients with lymphomas were more at risk than those with other haematological malignancies. The study, led by Dr Livio Pagano,...
Continue Reading
Nichola Oakenfull is partially vaccinated against Covid-19, but she’s still scared. The Wellington woman was diagnosed with multiple myeloma (a type of blood cancer) during alert level 3 last year – a diagnosis that may reduce the efficacy of the Pfizer vaccine. “It is very scary because I’m doing as much as I can to try and keep myself safe, but you are relying...
Continue Reading
This article originally published on The Limbic Most parents of children undergoing active cancer treatment at the RCH Children’s Cancer Centre, Melbourne last year reported no change to their child’s care due to COVID-19. An online survey of more than 100 parents in October-November 2020 found 69% reported no change to their child’s treatment plan...
Continue Reading
People with blood cancers who are immunocompromised are now advised to have a third primary dose of COVID-19 vaccine with an mRNA vaccine. On 8 October the Australian Technical Advisory Group on Immunisation (ATAGI) recommended a booster third dose of vaccine as part of the primary course in individuals who are severely immunocompromised to address the risk...
Continue Reading
This article was originally posted on Stuff Around 21,000 Kiwis are living with blood cancer. Symptoms can be difficult to recognise, and experts worry that some people aren’t getting diagnosed as our health system tackles the impact of Covid-19. Hayley McLarin investigates. Neil Brownlie has beaten blood cancer three times in a decade. The former...
Continue Reading
This article was originally published on The Limbic Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher psychological distress from risk of COVID-19 infection and unmet needs, finds new research Over a year into the pandemic, we have all felt the effects at this point. But the disruptions and stress haven’t...
Continue Reading
Patients with blood cancer – including leukaemia, myeloma, and lymphoma – experience higher psychological distress from risk of COVID-19 infection and unmet needs, finds new research Over a year into the pandemic, we have all felt the effects at this point. But the disruptions and stress haven’t been spread evenly across the population and the...
Continue Reading
Dear Colleagues On behalf of Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) please find below our article of the week and the current IMS COVID-19 vaccination guidelines. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With CancerVan Poznak, Unger, Darke, Moinpour, Bagramian, Schubert, Hansen, Floyd, Dakhil, Lew, Wade, Fisch, Henry,...
Continue Reading
This article was originally posted on Docwirenews According to new data published in Blood, patients with multiple myeloma (MM) who are hospitalized for COVID-19 infection face higher mortality compared with patients without MM, with age, disease status, and renal involvement serving as predictors of worse outcomes. MM is a hematological cancer of the plasma cells, particularly within bone...
Continue Reading
This article was originally published on Multiple Myeloma Today ABSTRACT BACKGROUND: Patients with hematological malignancies (HM), including multiple myeloma (MM), frequently suffer from immune deficiency-associated infectious complications because of both the disease and the treatment. Alarming results from China and the UK confirm the vulnerability of HM patients to severe acute respiratory syndrome coronavirus 2...
Continue Reading
1 2

Floor 7, 90 The Terrace
Wellington Central
New Zealand